Digital Pathology Scanner

OptraSCAN Inc offers PD-L1 biomarker & immune-oncology biomarker analysis for immune-oncology – programmed death-ligand 1 (PD-l1) expression. Programmed Cell Death Ligand-1 expression of PD-L1 is a very important cancer biomarker and it has become a critical part of patient management for immunotherapy. The targeted blockade of PD-L1 helps to restore the antitumor response. Because of the development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors. It has been indicated that PD-L1 expression on both tumor and tumor-associated immune cells is associated with clinical outcomes. Optrascan’s Solution For Immuno - Oncology: -          -   It’s an automated image analysis (for research use) which supports the interpretation of PD-L1I HC expression on both tumor and immune cells in solid tumors. -          -=  They determines PD-L1 expression on tumor and immune cells showing partial or complete membrane staining on a tumor cell along with me

    Unparalleled Image Quality Within Seconds   SAN JOSE, Calif- OptraSCAN ®, the leading end-to-end digital pathology solution provider, announced the launch of OS-Ultra 320 the world’s first-ever affordable high-speed digital pathology scanner. The OS-Ultra 320 scans tissues/cells of size 15x15 mm area at 40x magnification in less than 60 seconds and features no-touch continuous loading operation. The OS-Ultra 320 is designed to reduce workflow errors and scale-up pathology laboratory operations.   “We are disrupting digital transformation of Pathology and Cytology through affordability,” said Abhi Gholap, Founder of OptraSCAN. “With our 15-slide scanner getting tremendous traction for small laboratories, we are happy to launch our high performance 320 slide scanning device at an economical pricing as a complete solution to scan-store-analyze-share the cases,” he further added. “OS-Ultra 320 represents a significant development in reducing technician time while maintaini